Nearly every American with prescription drug coverage has a pharmacy benefit manager working behind the scenes — yet most have never heard the term. What is a PBM? It stands for pharmacy benefit manager, and these companies serve as the invisible middlemen between your health plan, your pharmacy, and the drug companies that manufacture your medications. The three largest PBMs process prescriptions for more than 200 million people, according to the Federal Trade Commission. Whether you realize it or not, a PBM determines what you pay at the pharmacy counter.
PBMs Explained in Plain Terms
A pharmacy benefit manager is a company hired by your employer, health insurer, or government program to manage the prescription drug piece of your health benefits. PBMs do not manufacture drugs. They do not diagnose or treat patients. Instead, they occupy a powerful intermediary position, negotiating prices and deciding coverage rules.
Here is what a PBM actually does on a daily basis:
Formulary creation: The PBM builds a list of covered medications organized by cost tiers. Drugs on lower tiers cost you less. This list determines whether your medication is covered and how much you pay.
Price negotiation: PBMs negotiate rebates with drug manufacturers. In exchange for placing a drug on the formulary — especially on a favorable tier — the manufacturer pays the PBM a rebate, often 20% to 50% of the list price.
Claims processing: When you hand your insurance card to a pharmacist, the PBM’s system processes the claim in real time. It checks eligibility, applies formulary rules, and calculates your copay within seconds.
Pharmacy network management: PBMs contract with pharmacies to form networks, negotiating the reimbursement rates those pharmacies receive for dispensing drugs.
Utilization management: PBMs implement tools like prior authorization, step therapy, and quantity limits to control drug spending and, in theory, promote appropriate use.
The Big Three PBMs
Market concentration is extreme. Three companies dominate the PBM industry:
CVS Caremark — Part of CVS Health, which also owns CVS Pharmacy retail stores and Aetna insurance. CVS Caremark manages benefits for over 110 million members.
Express Scripts — Owned by The Cigna Group. Express Scripts processes more than one billion prescriptions annually and holds the TRICARE pharmacy contract for the U.S. military.
OptumRx — A subsidiary of UnitedHealth Group, parent of UnitedHealthcare. OptumRx manages pharmacy benefits across commercial, Medicare, and Medicaid populations.
Together, these three control approximately 80% of the prescription drug claims market. This level of concentration gives them enormous leverage over both drug manufacturers and pharmacies. Smaller PBMs — including Navitus Health Solutions, MedImpact, and Capital Rx — have carved out niches by offering transparent, pass-through pricing models as an alternative.
How PBMs Affect What You Pay
Your prescription cost is not determined solely by the drug’s price tag. The PBM’s decisions layer on top of that base price to produce the number you see at checkout.
Consider a brand-name cholesterol medication with a list price of $400 per month. The manufacturer might pay the PBM a $120 rebate to place the drug on Tier 2 instead of Tier 3. Your copay at Tier 2 might be $40, while Tier 3 would cost you $75. The PBM’s rebate negotiation directly saved you $35 — but the PBM may also retain a portion of that $120 rebate rather than passing it to the health plan.
This is where the system gets complicated. Critics argue that PBMs sometimes favor drugs with higher rebates over drugs that are clinically equivalent but cheaper, because the rebate revenue is more profitable for the PBM. The net effect can be higher list prices industry-wide, since manufacturers raise list prices to fund larger rebates.
The Rebate System Under Scrutiny
Rebates are the most debated aspect of PBM operations. Drug manufacturers pay billions in rebates to PBMs each year. According to KFF (Kaiser Family Foundation), manufacturer rebates on brand-name drugs exceed $200 billion annually. The question is who benefits from those rebates.
In a fully pass-through arrangement, the PBM forwards 100% of rebates to the health plan, which can use them to lower premiums or reduce copays. In a traditional arrangement, the PBM retains a percentage of the rebates as revenue. The FTC found that PBM-retained rebate revenue has grown significantly over the past decade, raising concerns that the current system primarily benefits PBM shareholders rather than patients.
Some employers and government programs have responded by switching to transparent PBMs that guarantee 100% rebate pass-through. These arrangements shift the PBM’s revenue model to flat administrative fees, removing the incentive to favor high-rebate drugs.
Vertical Integration: Why It Matters
Each of the Big Three PBMs is owned by a larger healthcare company that also operates health insurance, retail pharmacies, or both. This vertical integration raises specific concerns about conflicts of interest.
When CVS Health owns the PBM (CVS Caremark), the insurer (Aetna), and the pharmacy (CVS Pharmacy), it can design benefit structures that steer patients toward CVS-owned pharmacies — even if an independent pharmacy is more convenient or offers better service. Similarly, UnitedHealth Group’s ownership of OptumRx and UnitedHealthcare creates incentives to keep patients within the OptumRx ecosystem.
The FTC’s interim report on PBMs highlighted these integration concerns, noting that vertically integrated PBMs may disadvantage independent pharmacies and limit patient choice. Congressional hearings in 2024 and 2025 have focused heavily on whether structural separation — forcing PBMs to divest from insurance companies or pharmacies — would improve competition.
PBM Reform Efforts
Bipartisan frustration with PBMs has produced a wave of legislative activity. At the state level, more than 40 states have enacted some form of PBM regulation, including licensure requirements, prohibitions on spread pricing in Medicaid, and mandates for rebate transparency.
At the federal level, several bills aim to reform PBM practices. Key proposals include requiring PBMs to pass through 100% of rebates to the point of sale, banning spread pricing in Medicare and Medicaid, establishing fiduciary duties requiring PBMs to act in their clients’ best interest, and increasing reporting requirements to federal agencies. Our PBM reform article provides a detailed look at these legislative efforts.
Frequently Asked Questions
Do I get to choose my PBM?
No. Your employer or health insurer selects the PBM. If you buy insurance on the marketplace, the insurer has already contracted with a PBM. You interact with the PBM your plan has chosen, though you always have the option to pay cash for prescriptions if the price is lower than your copay.
Are PBMs regulated?
PBM regulation is a patchwork. There is no comprehensive federal law governing PBMs, though they are subject to certain Medicare and Medicaid rules when managing government program benefits. State regulation varies widely — some states require PBM licensure, while others have minimal oversight. Federal reform bills are advancing but have not yet been enacted as of early 2026.
How do PBMs differ from pharmacies?
A pharmacy dispenses medications directly to patients. A PBM manages the insurance side — determining coverage, processing claims, and negotiating prices. Some PBMs own pharmacies (CVS Caremark owns CVS Pharmacy), but the PBM function and the pharmacy function are distinct operations.
Can a PBM deny my prescription?
A PBM can deny insurance coverage for a prescription, meaning your plan will not pay for it. This is different from a pharmacy refusing to dispense the drug. Common reasons for denial include the drug not being on formulary, prior authorization not being obtained, or quantity limits being exceeded. You can always pay the cash price or appeal the denial through your doctor.
What This Means for You
Now that you know what a PBM is, use that knowledge strategically. Review your formulary annually — it changes every year. Compare prices at different pharmacies in your network, as copays can vary by pharmacy. Ask your doctor about generic or preferred alternatives when a medication has a high copay. And if a medication is denied, pursue the appeals process with proper clinical documentation.
For more on how PBMs connect to the broader healthcare landscape, including insurance design and healthcare costs, visit our healthcare policy guide.